This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Branam Oral Health Announces New Distribution Deal With

Branam Oral Health Technologies, Inc. is announcing a new national distribution contract with giving the company direct access to over three million online customers for its innovative line of pediatric dental care products. “This agreement proves that a wide range of consumers want all-natural dental care products for their children,” said Branam CEO Mick Janness.

The Centers for Disease Control and Prevention recognizes early childhood tooth decay as the most chronic childhood disease in America, affecting 28% of all children under the age of six with an estimated annual impact of over $1.74 Billion to the U.S. healthcare system. Branam Oral Health seeks to reverse this trend by developing products that prevent rather than just treat this disease. Health industry professionals well understand that an individual’s oral health is linked to general health. The all-natural Branam™ product line was developed by Dr. Stephen R. Branam, a pediatric dentist who has practiced preventive and restorative dentistry for over 33 years. will feature the complete line of Branam’s all-natural dental care products that are focused on preventing childhood tooth decay. Unlike other products on the market, the Branam line is formulated with a rich supply of Xylitol, an all-natural ingredient derived from plant and fruit fibers. Clinical studies show that Xylitol is highly effective in combating the bacteria that lead to chronic ear infections and tooth decay.

The key differentiating factor of the Branam product line is the level of Xylitol in the formulations. “Studies show that Xylitol is most effective in combating specific bacteria strains when six to ten grams are consumed throughout the day,” stated Dr. Michael Marderosian, a respected general dentist and member of the Branam Scientific Advisory Board. “This is easily achieved when using the range of products the Branam line has to offer without having to change or adopt new behaviors.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs